Long-term outcome of giant cell tumor of bone involving sacroiliac joint treated with selective arterial embolization and curettage: a case report and literature review

World Journal of Surgical Oncology

ZhiHou Fu¹  SongFeng Xu¹  Ming Xu¹  XiuChun Yu¹ 

[1] Orthopedic Department, General Hospital of Jinan Military Commanding Region, Jinan, 250031, China

关键词: Long term outcome;    Curettage;    Selective arterial embolization;    Pelvis;    Sacrum;    Giant cell tumor of bone;   

Others  :  825829
DOI  :  10.1186/1477-7819-11-72

 received in 2012-10-04, accepted in 2013-02-23,  发布年份 2013

【 摘 要 】

Background

Giant cell tumor of the sacrum, especially involving the sacroiliac joint, is rare, but is particularly challenging to treat. The long term outcome of a patient was studied with giant cell tumor involving the sacroiliac joint treated with selective arterial embolization and curretage.

Method

One patient with giant cell tumor involving the sacroiliac joint was treated with selective arterial embolization and curettage in our hospital in October 2002. The curettage and bone grafting was done after two times of selective arterial embolization;1600 ml of blood were transfused and no complications developed during the operation.

Results

At the final follow-up of 9 years after the operation, no local recurrence and metastasis developed and she retained normal activity in daily life.

Conclusion

We think it is an optimal treatment for giant cell tumor involving the sacroiliac joint, with repeated selective arterial embolization and curettage, which has the advantage of less injury, less blood loss and fewer complications.

【 授权许可】

   
2013 Yu et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

【 参考文献 】

• [1]Lackman RD, Khoury LD, Esmail A, Donthineni-Rao R: The treatment of sacral giant-cell tumours by serial arterial embolisation. J Bone Joint Surg Br 2002, 84(6):873-7.
• [2]Turcotte RE, Sim FH, Unni KK: Giant cell tumor of the sacrum. Clin Orthop Relat Res 1993, 291:215-21.
• [3]Hosalkar HS, Jones KJ, King JJ, Lackman RD: Serial arterial embolization for large sacral giant-cell tumors: mid- to long-term results. Spine (Phila Pa 1976) 2007, 32(10):1107-1115.
• [4]Lin PP, Guzel VB, Moura MF, Wallace S, Benjamin RS, Weber KL, Morello FA Jr, Gokaslan ZL, Yasko AW: Long-term follow-up of patients with giant cell tumor of the sacrum treated with selective arterial embolization. Cancer 2002, 95(6):1317-25.
• [5]Ozaki T, Liljenqvist U, Halm H, Hillmann A, Gosheger G, Winkelmann W: Giant cell tumor of the spine. Clin Orthop Relat Res 2002, 401:194-201.
• [6]Simpson AH, Porter A, Davis A, Griffin A, McLeod RS, Bell RS: Cephalad sacral resection with a combined extended ilioinguinal and posterior approach. J Bone Joint Surg Am 1995, 77(3):405-11.
• [7]Doita M, Harada T, Iguchi T, Sumi M, Sha H, Yoshiya S, Kurosaka M: Total sacrectomy and reconstruction for sacral tumors. Spine (Phila Pa 1976) 2003, 28(15):E296-301.
• [8]Leggon RE, Zlotecki R, Reith J, Scarborough MT: Giant cell tumor of the pelvis and sacrum: 17 cases and analysis of the literature. Clin Orthop Relat Res 2004, 423:196-207.
• [9]Gottfried ON, Schmidt MH, Stevens EA: Embolization of sacral tumors. Neurosurg Focus 2003, 15(2):E4.
• [10]Thangaraj R, Grimer RJ, Carter SR, Stirling AJ, Spilsbury J, Spooner D: Giant cell tumour of the sacrum: a suggested algorithm for treatment. Eur Spine J 2010, 19(7):1189-94.